Cyclerion Therapeutics Inc (CYCN)
3.04
+0.27
(+9.75%)
USD |
NASDAQ |
Apr 25, 16:00
3.17
+0.13
(+4.28%)
After-Hours: 20:00
Cyclerion Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -18.59K% |
| March 31, 2022 | -5.77K% |
| December 31, 2021 | -5.92K% |
| September 30, 2021 | -14.66K% |
| June 30, 2021 | -539.4% |
| March 31, 2021 | -21.61K% |
| December 31, 2020 | -14.46K% |
| Date | Value |
|---|---|
| September 30, 2020 | -4.70K% |
| June 30, 2020 | -2.61K% |
| March 31, 2020 | -1.99K% |
| December 31, 2019 | -1.76K% |
| September 30, 2019 | -1.95K% |
| June 30, 2019 | -1.98K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-21.61K%
Minimum
Mar 2021
-539.4%
Maximum
Jun 2021
-7.43K%
Average
-4.70K%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 23.41% |
| iBio Inc | -- |
| AbbVie Inc | 5.75% |
| Agile Therapeutics Inc | -123.7% |
| NovaBay Pharmaceuticals Inc | -110.2% |